Page last updated: 2024-08-17
triamcinolone acetonide and Myelodysplastic Syndromes
triamcinolone acetonide has been researched along with Myelodysplastic Syndromes in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kozaki, S; Mayuzumi, M; Murata, J; Nishie, W; Ohnishi, K; Sato-Matsumura, KC; Shibaki, H | 1 |
Other Studies
1 other study(ies) available for triamcinolone acetonide and Myelodysplastic Syndromes
Article | Year |
---|---|
Multiple nodules on the face and in the nasal cavity are the symptoms of vegetative pyoderma gangrenosum complicated with myelodysplastic syndrome.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Face; Facial Dermatoses; Humans; Male; Myelodysplastic Syndromes; Nasal Cavity; Prednisolone; Pyoderma Gangrenosum; Treatment Outcome; Triamcinolone Acetonide | 2006 |